• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Both Patients and Physicians Perceive Blood Transfusions as Risky

June 6, 2014

In non-trauma cases, the decision to transfuse is usually made jointly between the patient and the physician. A recent survey-based study from one US hospital found that both patients (N=294) and physicians (N=73) assume different risks regarding transfusions.

Twenty percent of the patients and almost 40% of the physicians surveyed considered transfusions as “very often risky” or “always risky.” However, when asked about 5 specific adverse events that can occur during transfusions, physicians had fewer concerns than patients. They also found that certain patient populations, specifically African Americans or patients with a high school education or less, had a greater perceived risk of transfusion complications. Better education about the risks of transfusions is needed for both patients and physicians.

References

1. Toledo P. Shared decision-making and blood transfusions: is it time to share more? Anesthesia and analgesia 2014; 118(6): 1151-3.
2. Vetter TR, Adhami LF, Porterfield JR, Jr., Marques MB. Perceptions about blood transfusion: a survey of surgical patients and their anesthesiologists and surgeons. Anesthesia and analgesia 2014; 118(6): 1301-8.

 

 

Filed Under

  • Adverse Events (non-infectious)
  • News
  • RBC Transfusion

Recommended

  • CRISPR-Cas9 Gene Editing and Lentiviral Gene Therapy Hold Promise to Treat Transfusion Dependent β-Globin Hemoglobinopathies

  • VIDEO: Murine Model for Hemolytic Disease of the Fetus and Newborn

  • Platelet Markers Associated with Bleeding in Immune Thrombocytopenia Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

  • Oropouche Virus RNA Detected in Blood Donors in Brazil

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley